Regulus Therapeutics
RGLS
#8604
Rank
$0.13 B
Marketcap
$2.06
Share price
6.19%
Change (1 day)
-11.97%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -$46.2 Million USD

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$29.44 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -$46.2 Million56.97%
2023 -$29.44 Million6.51%
2022 -$27.64 Million2.53%
2021 -$26.96 Million93.59%
2020 -$13.93 Million-15.41%
2019 -$16.46 Million-64.46%
2018 -$46.31 Million-33.26%
2017 -$69.38 Million-13.98%
2016 -$80.66 Million44.77%
2015 -$55.72 Million-1.63%
2014 -$56.64 Million203.6%
2013 -$18.66 Million8.65%
2012 -$17.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$4.39 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.94 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
$1.90 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.43 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.24 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-$98.45 Million 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.38 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.12 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA